CAR-T Meeting 2024 | Novel CAR T-cell therapies for hematological malignancies: exploring new targets
He Huang
• 16 Feb 2024
In this video, He Huang, MD, PhD, Zhejiang University School of Medicine, Zhejiang, China, discusses his talk on the novel CAR T-cell therapies for treating hematological malignancies. CAR-T has revolutionized the treatment of patients; however, some challenges remain. For those patients who relapse following treatment with currently available CAR-T products, there is an unmet need to develop CAR-T cells with novel targets, for example, CD7 or GPRC5D. This interview took place at the EBMT-EHA 6th European CAR T-cell Meeting in Valencia, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
